Magnitude Biosciences

Contract research on C. elegans models and automated imaging for drug discovery, nutraceutical and consumer-goods R&D

Sedgefield, United KingdomFounded 2018magnitudebiosciences.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Magnitude Biosciences

Magnitude Biosciences is a contract research organisation that runs customised C. elegans studies with automated imaging technology for industry and academic research projects. Its services cover ageing and longevity, microbiome, neurodegeneration, toxicity and transgenics. The VivoScan platform provides whole-organism high-throughput screening, and WormGazer is a technology the company offers alongside it.

Its customers include biotechnology and pharmaceutical companies, health products and ingredient firms, manufacturers in agri and green manufacturing, and academic researchers. Clients commission customised studies designed to answer their specific research questions.

The company was founded in 2018 by a team of C. elegans and automated imaging researchers. It is registered in England and Wales and is based in Sedgefield, United Kingdom. Its leadership team includes Dr. Fozia Saleem as CEO and Dr. Chris Saunter as CTO.

Product: Contract C. elegans research studies with automated imaging, plus the VivoScan high-throughput screening platform and WormGazer technology.

Jobs at Magnitude Biosciences

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Mahashiv

    Pharmaceutical development and manufacturing services for pharmaceutical companies
    Ilford, United KingdomBiotech & pharmaFounded 2019
    New on Evolc
  • Manteisbio

    Scientific and drug-development consulting for biotech, pharma, virtual companies, investors and public organizations
    London, United KingdomBiotech & pharmaFounded 2025
    Young companyNew on Evolc
  • Manx Healthcare

    UK pharmaceutical manufacturer and distributor supplying generic and over-the-counter medicines to healthcare customers
    Warwick, United KingdomBiotech & pharmaFounded 1994
  • Mariposa Therapeutics

    Develops topical therapies for people with Epidermolysis Bullosa Simplex and other keratin-related conditions
    Cardiff, United KingdomBiotech & pharmaFounded 2019
    New on Evolc
  • Matheus Engineering

    Contract process engineering research and scale-up services for pharmaceutical and chemical manufacturers
    Sandwich, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Matrix Science

    Proteomics software for researchers and scientists identifying and quantifying proteins from mass spectrometry data
    London, United KingdomBiotech & pharmaFounded 1998

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Microsoft ClarityMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Backend

  • PHPMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

  • HubSpotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.